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An intriguing novel pathophysiological insight into mood disorders is the notion that one’s metabolic
status inﬂuences mood. In rodents, cocaine- and amphetamine-regulated transcript (CART) and nesfatin-
1/NUCB2 have not only been implicated in metabolism, but in the pathobiology of anxiety and
depressive-like behaviour, however they have not previously been investigated in depressed subjects.
Both peptides are highly expressed in centrally projecting neurons in the Edinger-Westphal nucleus
(EWcp) in the midbrain. The EWcp has been implicated in stress adaptation and stress-related mood
disorders like major depressive disorder in a sex-speciﬁc manner. This is intriguing, given the fact that
females have higher prevalence of mood disorders. Here, we hypothesized that the expression of CART
and nesfatin-1 in EWcp would exhibit a sex-speciﬁc difference between depressed suicide victims vs.
controls. We found that CART and nesfatin/NUCB2 colocalized in the human EWcp, and that CART mRNA
content was much higher in both male (3.8) and female (5.9) drug-free suicide victims than in
controls (persons who died without any diagnosed neurodegenerative or psychiatric disorder). Similarly,
NUCB2 mRNA content was also higher (1.8) in male suicides, whereas in female suicide victims, these
contents were 2.7 lower compared to controls. These observations are the ﬁrst to show changes in the
dynamics of CART and nesfatin/NUCB2 expressions in the midbrain of drug-free depressed suicide
victims vs. controls.
This article is part of a Special Issue entitled ‘Anxiety and Depression’.
 2011 Elsevier Ltd. All rights reserved.1. Introduction
Unravelling the pathobiology of major depressive disorder (MDD)
is amajor challenge. Recently signiﬁcant interest has arisen inpossible
interactions between central mood substrates and circuitries involved
in metabolism (Gomez-Pinilla, 2008; Krishnan and Nestler, 2008;
Kuperman et al., 2010; McBriar, 2006; Shao et al., 2008). More
speciﬁcally, several neuropeptides with a clear role in metabolism,
suchas leptin, ghrelin, orexin, neuropeptideYandurocortin3, produce
clear anti-depressant-like responses (Eaton et al., 2007; Heilig, 2004;
Kuperman et al., 2010; Lu, 2007; Lutter et al., 2008; Yamada et al.,31243652714.
rk.
All rights reserved.2011), whereas e.g. melanin-concentrating hormone and cholecysto-
kinin evoke a pro-depressant-like phenotype in several rodentmodels
(Becker et al., 2008; Georgescu et al., 2005).
To further support this notion, we have focused in the present
study on two neuropeptides implicated in energy metabolism, viz.
cocaine- and amphetamine-regulated transcript peptide (CART;
(Douglass et al., 1995) and the recently identiﬁed nesfatin-1 (Oh
et al., 2006). The highest expression of CART and nesfatin-1 in
rodents is in centrally projecting neurons in the midbrain Edinger-
Westphal nucleus (EWcp; Brailoiu et al., 2007; Couceyro et al.,
1997; Koylu et al., 1998; Kozicz, 2003; Kozicz et al., 2011a). The
EW has originally been identiﬁed as the source of the preganglionic
parasympathetic outﬂow to the ciliary ganglion (Edinger, 1885;
Westphal, 1887) with preganglionic autonomic neurons exhibit-
ing choline acetyltransferase (ChAT) immunoreactivity (Kozicz
et al., 2011a). However, the discovery of a distinct population of
B. Bloem et al. / Neuropharmacology 62 (2012) 297e303298neurons that do not colocalize with ChAT immunoreactivity, and
produce urocortin-1, CART and nesfatin-1 (Brailoiu et al., 2007; Foo
et al., 2008; Koylu et al., 1998; Kozicz et al., 1998, 2011a; Vaughan
et al., 1995; Xu et al., 2010), neuropeptides tied to the stress
response and stress-relatedmood disorders such as depression, has
markedly extended our insight into the functional signiﬁcance of
this midbrain nucleus (for reviews see: Garcia-Galiano et al., 2010;
Gysling et al., 2004; Kozicz, 2007; Kozicz et al., 2011b; Pan and
Kastin, 2008; Rogge et al., 2008; Skelton et al., 2000).
The possible signiﬁcance of CART in stress-related psychopa-
thologies derives from the facts that a) CART mRNA is down-
regulated in the frontal cortex of rats subjected to a chronic mild-
stress (Orsetti et al., 2008); b) CART-immunoreactivity is increased
in the periaqueductal grey in a genetic rat model for depression
(Flinders-Sensitive-Line-FSL; (Wiehager et al., 2009); and c) CART-
immunoreactivity is reduced in various brain areas of socially iso-
lated and olfactory bulbectomized rats (Dandekar et al., 2008).
Furthermore, a study of an Italian family with high levels of anxiety
and MDD has indicated an association between these disorders and
a point mutation in the CART gene (Miraglia del Giudice et al., 2006).
Nesfatin-1 is a product of the NEFA/nucleobindin 2 (NUCB2) gene,
and was recently identiﬁed as a potent satiety agent (Oh et al., 2006).
NUCB2 is a precursor protein that is cleaved by prohormone con-
vertases into multiple fragments with largely unknown biological
functions (Foo et al., 2008; Oh et al., 2006). Upon intra-
cerebroventricular administration, nesfatin-1 exerts, besides a strong
anorexigenic action, anxiogenic effects as well (Garcia-Galiano et al.,
2010; Merali et al., 2008). Interestingly, Ari et al. have recently
demonstrated higher plasma nesfatin-1 levels in patients with MDD
that is positively correlating with the Hamilton Depression Rating
scale (Ari et al., 2011).
The possible involvement of CART and nesfatin-1 in stress-
related human psychopathologies such as MDD has not been
investigated. Therefore, in this study, we ﬁrst studied the presence
of CART and nesfatin/NUCB2 peptides in the post-mortem micro-
dissected human EWcp and subsequently analyzed the dynamics
of their mRNA expression in drug-free, depressed suicide victims,
in comparison to non-depressed individuals, who died without anyTable 1
Clinicopathological information and CART/NUCB2 expression values of suicide victims a
Sex Age (years) Body composition Diagnosis Post-mortem
delay (h)
Antidepressive
medication in the
last 3 months
Cause
M 51 Average Control 5 None Cardi
M 42 Average Control 3,5 None Acute
M 53 Average Control 5 None Pulm
M 55 Below average Control 1 None Myoc
M 47 Below average Control 2 None Acute
M 63 Average Control 2 None Acute
M 56 Average Control 2 None Acute
M 47 Average Control 2 None Acute
F 72 Average Control 4,5 None Acute
F 79 Average Control 4,5 None Acute
F 56 Average Control 5 None Myoc
F 86 Average Control 4,5 None Acute
F 56 Average Control 5 None Myoc
F 79 Average Control 4,5 None Acute
F 78 Obese Control 1,5 None Pulm
F 72 Average Control 3,5 None Myoc
M 52 Average MD/suicide 2,5 None Hang
M 31 Average MD/suicide 6 None Hang
M 43 Average MD/suicide 3 None Hang
M 42 Average MD/suicide 4 None Hang
M 32 Below average MD/suicide 6 None Hang
F 42 Average MD/suicide 3 None Hang
F 42 Below average MD/suicide 3 None Hang
F 42 Average MD/suicide 11 None Hang
Abbreviations: HBB-Human Brain Bank Budapest Hungary; M-male; F-female; MD-majodiagnosed neurodegenerative or psychiatric disorder (controls).
Since women are twice as vulnerable to MDD as men (Gorman,
2006; Weissman et al., 1996), we investigated whether the results
would be sex-speciﬁc.
2. Material and methods
Brains were obtained at autopsy from the Department of Forensic Medicine of
Semmelweis University, Budapest, micro-dissected, and stored in the Human Brain
Tissue Bank, Budapest. All subjects were males and females of Caucasian origin from
Hungary (Budapest region), and post-mortem brain samples of these subjects were
earlier used and described in detail in a previous study (Kozicz et al., 2008).
Brieﬂy, exclusion criteria for subjects included the presence of prolonged agonal
state or extended illness. Furthermore, since post-mortem delay can signiﬁcantly
alter gene expression proﬁles (Atz et al., 2007; Ervin et al., 2007; Vawter et al., 2006),
subjects with a post-mortem delay longer than 12 h were also excluded from the
present account. Brains from suicide victims with MDD (5 males and 3 females) and
from controls (8 males and 8 females) were studied. Male subjects were matched for
age and post-mortem delay (Table 1). The average age of male controls and suicide
victims was 53.0  7.3 and 40.0  8.7 years, respectively. The average post-mortem
delays were 2.7  1.6 for male controls and 4.3  1.6 h for male suicide victims. No
statistical difference was found between the average ages (p ¼ 0.107) and post-
mortem delays (p ¼ 0.092) of male controls and suicide victims. Female subjects
were matched for post-mortem delay (Table 1). The average post-mortem delays
were 4.3  1.6 for female controls and 5.7  4.6 h for female suicide victims. No
statistical difference was found for post-mortem delay between female controls and
suicide victims (p ¼ 0.97). The relatively low number of available samples of female
suicide victims with a short pot-mortem delay (<12 h) in the Human Brain Tissue
Bank, however, has compromised age-matching of female controls and suicide
victims. Female controls (average age: 72.3  10.9) were signiﬁcantly (p ¼ 0.001)
older then female suicide victims (average age: 42.0  0.0). This apparent limitation
in the study design will be addressed in detail in the discussion.
The medical, psychiatric and drug history of all suicide victims was obtained
through chart review coupled with interviews with the attending physician(s)/
psychiatrist(s) and family members. Psychiatric evaluation for every suicide victim
was made using psychological autopsies. Brieﬂy, DSM-IV (Diagnostic and Statistical
Manual of Mental Disorders, Fourth Edition) diagnoses were established by a panel of
clinicians based on information obtained by means of proxy-based interviews
complemented by medical and coroner records. Subjects included in this investi-
gation consisted of suicides with MDD (non-bipolar depression) with recurrent
episodes, who also died during an episode of major depression (Table 1). Suicide
victimswith a history of schizophrenia, epilepsy, or alcohol or other drug abusewere
not included in the studies. Victims died by hanging (5 males and 2 females) or drug
overdose (one female; there is no data about the drug used in her medical history).
Some of the suicide victims had previously been treated for major depression, butnd control subjects.
of death CART mRNA
expression in AU
NUCB2 mRNA
expression in AU
ac arrest; arrhythmia 0.43 2.88
respiratory failure; cardiac ischemia 0.03 1.99
onary embolism 1.36 1.43
ardial infarction 7.80 1.28
cardiavascular failure; pulmonary embolism 0.06 3.53
cardiovascular failure 0.24 1.71
cardiovascular failure 0.05 2.73
cardiovascular failure; coronary ischemia 0.03 4.01
coronary ischemia 0.62 16.8
respiratory insufﬁciency 0.26 0.83
ardial infarction 0.02 1.15
cardiovascular and respiratory insufﬁciency 0.04 2.13
ardial infarction 0.05 5.23
cardiovascular and respiratory insufﬁciency 0.04 1.4
onary embolisms 1.20 2.52
ardial infarction 0.04 0.42
ing 3.74 2.00
ing 0.80 8.35
ing 1.62 4.49
ing 2.14 2.01
ing 0.22 4.16
ing 3.59 1.35
ing 0.61 0.50
ing 0.76 0.88
r depression; CSF-cerebrospinal ﬂuid.
Table 2
Primer sequences.
Acc. number Reverse; ‘5-.-3’ Forward; ‘5-.-3’
hGAPDH NM002046 ATGGCATGGACTGTG
GTCATG
ATCATCAGCAATGCCTCCTGC
hCART NM004291 AGCGCTTCGATCAGCTCCT CCGAGCCCTGGACATCTACTC
hNUCB2 NM005013 AGTTCATCCAGTCTC
GTCCTCAC
TGGAAACAGATCCGCATTTCA
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reliably obtained in each case (Table 1). Nevertheless, psychological autopsy and
medical records indicated that none of the persons included in the study had
received antidepressant medication for at least 2 months before death. In addition,
toxicological tests on blood samples did not reveal the presence of drugs or alcohol
in cases of death by hanging (Table 1).
All controls died of a sudden death (Table 1). The causes of death were acute
cardiac-respiratory failure or myocardial infarction. Psychological autopsy based on
medical records conﬁrmed the absence of psychiatric illness, antipsychotic medi-
cations and alcohol or drug abuse during the last 10 years. In addition, systematic
neuropathological analysis (histopathology) did not show any neurodegenerative
disorder for any person (Table 1). Harvesting of tissues was approved by the local
ethics committee of Semmelweis University, and informed written consent had
been obtained for use of brain material and clinical data from next of kin.
2.1. Microdissection of the EWcp
At the time of dissection, midbrains were sliced into 1 mm thick coronal sections,
at 0 and -10 C. Under a stereomicroscope, samples from the rostral ventral portion of
the midbrain, including the ventral central grey, oculomotor nuclei and Cajal nucleus,
but dominated by the EWcp, weremicro-dissectedwith a 1.5mmmicropunch needle
(Ted Pella; Redding CA, USA). This approach allowsminimal variations in the size and
weight of the micro-dissected samples. Tissue samples from 3 consecutive sections
were collected in Eppendorf tubes, and stored at 70 C until further use.
2.2. Immunohistochemistry
Midbrains including the EWcp of twomale controls weremicro-dissected and ﬁxed
by immersion in 4% paraformaldehyde, for 48 h at 4 C. Subsequently, serial 30 mm thick
coronal sections (perpendicular to the midbrain axis) were cut at the level of the
superior colliculus on a freezing microtome (Microm GmBH, Walldorf, Germany).
Immunohistochemistry was performed according to our standard protocol
(Kozicz et al., 2008). Brieﬂy, after rinsing sections were treatedwith 0.5% Triton X-100
(Sigma-Aldrich, Zwijndrecht, The Netherlands), for 30 min, to enhance antigen
penetration. The they were incubated in a mixture of the following primary antisera
in 2% NDS, for 48 h at 4 C: (1) polyclonal (rabbit) anti-nesfatin-1 (human: H-003-97;
rat: H-003-22B; Phoenix Pharmaceutical, Inc.) at 1:1000, and (2)monoclonal (mouse)
anti-CART (Ca6-1 F4D4, generous gift fromDr J.T. Clausen, Novo Nordisk A/S, Bagverd,
Denmark) at 1:1500. The high speciﬁcity of these antisera has been described in detail
before (anti-nesfatin: (Xu et al., 2009) and anti-CART: (Kozicz, 2003). Brieﬂy, omitting
the primary antisera, or preabsorbing them with excess of the respective immuno-
genic synthetic protein/peptide against which they had been raised (nesfatin-1; Cat
No.: 003-22-A; Phoenix Pharmaceuticals; CART; gift from Dr J. T. Clausen, Novo
Nordisc A/S, Bagverd, Denmark) fully abolished immunoreactivity. The secondary
antisera (Jackson ImmunoResearch, Newmarket, Suffolk, UK) Cy2-conjugated anti-
mouse IgG (1:100) and Cy3-conjugated anti-rabbit IgG (1:100) were applied for 3 h.
Following several rinses in PBS, sections were mounted on glass slides and incubated
in 2% Sudan black, for 5 min, to block non-speciﬁc background ﬂuorescence.
Digital images were taken using a Leica confocal laser scanning microscope
(Leica Microsystems TCS SP2 AOBS system; Leica).
2.3. RNA extraction and cDNA synthesis
The micropunched tissue samples were collected in 500 ml ice-cold Trizol (Life
Technologies, Paisley, UK). RNA was extracted with chloroform, precipitated with
isopropyl alcohol, and dissolved in 30 ml RNAse-free DEPC. Total RNA was measuredFig. 1. Representative photomicrographs depicting the distribution and colocalization of CA
are merged confocal images depicting the colocalization of CART and nesfatin-1. Picture D is
human midbrain. Scale bars; AeC: 200 mm and D: 50 mm. EWcp-Edinger-Westphal nucleuswith an Eppendorf Biophotometer (Vaudaux-Eppendorf AG, Basel, Switzerland).
First-strand cDNA synthesis was performed using 1 mg RNA dissolved in 11 ml RNAse-
free DEPC containing 0.25 mU pd(N)6 (random primers; Roche, Almere, The
Netherlands), at 70 C for 10 min, followed by double-strand synthesis in 1 strand
buffer (Life Technologies) with 10 mM DTT, 20 U Rnasin (Promega, Madison, WI,
USA), 0.5 mM dNTPs (Roche) and 100 U reverse transcriptase (Superscript II; Life
Technologies), at 37 C for 75 min and at 95 C for 10 min.
2.4. Quantitative RT-PCR
Quantitative RT-PCRwas carriedout according to our standard protocol (Derks et al.,
2008; Kozicz et al., 2008), using, in brief, a total volume of 25 ml buffer solution con-
taining 5 ml of template cDNA, 12.5 ml SYBR Green Master mix (Applied Biosystems,
Foster City, CA, USA), 1.5 ml DEPC-treated MQ and 15 mM of each primer. Primers for
GAPDH, CARTand NUCB2were designed using Vector PrimerExpress software (Applied
Biosystems) based on the respective rat cDNA sequences (for details see Table 2). Primer
efﬁciencies (PE) were between 1.8 and 2.1 throughout all runs. Results of RT-PCR data
were presented as threshold cycle (Ct) values, with Ct deﬁned as the Ct of RT-PCR at
which the ampliﬁed product was ﬁrst detected. Melting curve analysis showed a single
component conﬁrming the formation of a speciﬁc PCR product. All qRT-PCR reactions
were carried out in triplicate. Data were analyzed using an equation in which average
fold change in target gene expression equalled PEΔΔCt. The ΔΔCt was calculated as
average Ct of target minus average Ct of GAPDH. The resulting ΔΔCt values were then
converted to a linear form by the PEΔΔCt method (Livak and Schmittgen, 2001).
2.5. Statistical analysis
The results are presented as mean  standard error of the mean (SEM). To
compare the data between experiment groups, two-way analysis of variance
(ANOVA; StatSoft, Tulsa OK, USA) with “victim status” and “gender” as independent
variables was performed. As data were not normally distributed, log-transformation
of data were performed on the basis of tests for normality (Shapiro and Wilk, 1965)
and for homogeneity of variance (Bartlett’s Chi-square test; (Snedecor and Cochran,
1989). Post-hoc analyses were carried out with Scheffe’s test (Hsu, 1996) using Sta-
tistica (StatSoft). Pearson’s R correlation test (StatSoft) was used to compare CART
and nesfatin/NUCB2 mRNA expression levels with the age, post-mortem time and
body composition of controls. In all cases alpha was 5%.
3. Results
3.1. Colocalization
Both CART-ir and nesfatin-1-ir was abundant in the human
EWcp, and colocalized in EWcp neurons (Fig. 1AeD).RT-ir and nesfatin-1-ir in the human (AeD) Edinger-Westphal nucleus. Figures C and D
a representative high power image of neurons coexpressing CART and nesfatin-1 in the
.
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CART and nesfatin/NUCB2 mRNAs were detected in micro-
dissected rostro-ventral midbrain samples containing the EWcp
of both controls and suicide victims. Two-way ANOVA revealed
a clear effect of “victim status” (F1,24 ¼ 4.38; p < 0.05). Post-hoc
analysis showed a signiﬁcant (p < 0.05) 3.8 times increase of CART
mRNA in age-matched male suicide victims vs. controls. CART
mRNA expression was 5.9 times higher (p < 0.005) in female
suicide victims vs. controls (Table 1 and Fig. 2A).
Next, we analyzed the nesfatin/NUCB2 mRNA contents of the
EWcp (Table 1 and Fig. 2B). Two-way ANOVA revealed a signiﬁcant
effect of ‘sex’ (F1,24 ¼ 8.23, p < 0.01) and ‘victim status by sex’
interaction (F1,24 ¼ 4.45, p < 0.05). In males, nesfatin/NUCB2 mRNA
content was 1.8 times higher in drug-free depressed suicide victims
vs. controls (p < 0.05). In female suicide victims, however, this
content was 2.7 times lower than that in controls (p < 0.05).
Since female suicide victims were younger than their female
controls, we tested for a possible effect of age on CARTand nesfatin/
NUCB2 mRNA expression. Pearson R correlation test revealed no
correlation between ‘age’ and CART mRNA or nesfatin/NUCB2
mRNA contents neither in male (r ¼ 0.43; p > 0.05) nor in female
(r ¼ 0.68; p > 0.05) controls. We also analyzed the effect of age on
CART and nesfatin/NUCB2 mRNA expression including all subjects.
We found no correlation between age and CART (r¼ 0.26; p> 0.05)
or age and nesfatin/NUCB2 (r ¼ 0.17; p > 0.05) mRNA abundance.
Also the CART and nesfatin/NUCB2 mRNA contents of the only
female suicide victimwith a drug-overdose were in the range of the
means of the two females that committed suicide by hanging.Fig. 2. Relative CART (A) and NUCB2 (B) mRNA expression in the EWcp of male
controls and drug-free depressed suicide victims, expressed as ΔΔCt values. The letters
in the bars represent experimental groups and the letter over the bars indicate the
experimental group with which signiﬁcant difference exists (Scheffe’s post hoc test;
p < 0.05). Error bars represent standard error of means.Statistical analysis of GAPDH mRNA expression did not reveal
any signiﬁcant difference (p > 0.05) among groups, supporting the
suitability of GAPDH mRNA to normalize the PCR-data.
4. Discussion
In this study, we have analyzed CART and nesfatin/NUCB2
contents of post mortem samples of rostro-ventral midbrains con-
taining the Edinger-Westphal nucleus of drug-free, depressed
suicide victims of both sexes. The results extend prior observations
on the possible involvement of CART and nesfatin/NUCB2 in MDD
in humans (Ari et al., 2011; Miraglia del Giudice et al., 2006) and in
anxiety- and depressive-like behaviour in rodents (Dandekar et al.,
2008; Garcia-Galiano et al., 2010; Merali et al., 2008; Wiehager
et al., 2009) in a number of ways. Firstly, we showed that CART and
nesfatin-1 were present and colocalized in EWcp neurons.
Secondly, we found that compared to controls, CART mRNA
expression was increased in male (nearly 4 times) and female
(nearly 6 times) suicide victims. Thirdly, nesfatin/NUCB2 mRNA
expression was higher in male (nearly 2 times), but lower (nearly 3
times) in female suicide victims than in corresponding controls.
Although the sample size utilized is admittedly small following
control for sample quality, we note that it was large enough to
detect consistent changes in CART and nesfatin/NUCB2 mRNA. A
further limitation is the analysis of only three female suicide
victims who were signiﬁcantly younger then female controls. In
theory, CART and nesfatin/NUCB2 mRNA expressions might be
inﬂuenced by age. To date no experimental evidence is available to
support an effect of age on CART and nesfatin/NUCB2 mRNA
expressions. In fact, in the present study no correlation between
age and CART and nesfatin/NUCB2 mRNA expression was found,
making a biasing inﬂuence of age on our data unlikely. Age could
also have an effect on reproductive hormone levels which in turn
could also inﬂuence the mRNA expression of CART and nesfatin/
NUCB2 in females. Unfortunately, no human studies are available
comparing CART and nesfatin/NUCB2 expression before and after
menopause. However, the magnitude of changes observed in this
study compared to changes in some brain substances in relation to
reproductive hormone levels are far bigger (Singh et al., 1995; Zhou
et al., 2005) suggesting that possible differences in reproductive
hormone levels alone cannot be accounted for the observed
differences, however this possibility has to be tested future studies.
While this study documents signiﬁcant changes in the expres-
sion of CART and nesfatin/NUCB2, it remains possible that factors
other than a history of MDD, including e.g. agonal state and suici-
dality, contribute to the ﬁndings. As to agonal state, gene expres-
sion proﬁles in the post mortem brain are inﬂuenced by asphyxia/
ischemia during agony (e.g. Atz et al., 2007; Ervin et al., 2007;
Vawter et al., 2006). Recently, Li et al. (2004) found that individ-
uals who suffered prolonged agonal states exhibited a consistent
change in expression of various genes, whereas those who expe-
rienced brief deaths caused by accidents, acute cardio-respiratory
events or asphyxia, generally did not (Li et al., 2004). Since in our
study samples were used of individuals with a brief death
(hanging), we believe that asphyxia cannot explain the differences
found in gene expression between groups, although it may have
randomly increased the variability of individual data.
With respect to suicidality, suicidal behaviour may be a unique
entity, reﬂecting the summations of various mechanisms in the
brain (van Heeringen, 2001), each of which may differ across
individuals, andmay not reﬂect those that governmajor depression
itself. While it might be considered that midbrain CART and nes-
fatin/NUCB2 dysregulation witnessed in this study indicates an
effect of suicidal behaviour rather than depression on pathobiology,
we feel that this is unlikely, because a similar increase in CART
B. Bloem et al. / Neuropharmacology 62 (2012) 297e303 301peptide in themidbrain periaqueductal grey was seen in genetic rat
models of depression (FSL rats; Wiehager et al., 2009), and an
association between depression and a point mutation in the CART
gene has been found in an Italian family (Miraglia del Giudice et al.,
2006).
Central injection of CART and nesfatin/NUCB2 into male rodents
increases anxiety (Koylu et al., 2006; Merali et al., 2008). This is in
line with our observation of increased CART and nesfatin/NUCB2
mRNA expressions in depressed suicide victims. The decreased
mRNA level of nesfatin/NUCB2 in females, however, suggest that
nesfatin/NUCB2 may have a sex-speciﬁc effect on anxiety, c.q.
anxiolysis. Although this would be plausible scenario, the ﬁnding
that plasma nesfatin-1 levels were elevated in both male and
female patients with MDD would argue against a sex-speciﬁc
involvement of nesfatin-1 in inﬂuencing mood (Ari et al., 2011).
Nonetheless, This issue has to be addressed and clariﬁed in future
studies.
Mutations in the human CART gene have been associated with
depression (Miraglia del Giudice et al., 2006), and increased CART
immunoreactivity is found in themidbrain periaqueductal grey and
in the hypothalamus of FSL rats that show increased depression-
like behaviour (Wiehager et al., 2009). The notion that CART may
play a role in the pathogenesis of major depression is further
corroborated by the fact that it can modulate signal transduction
pathways of neurotrophic factors such as brain-derived neuro-
trophic factor, and directly control the expression of genes coding
for key enzymes in the biosynthesis of serotonin, factors all
assumed to be involved in depression (for reviews see: Ma et al.,
2007; Pae et al., 2007; Rogge et al., 2008). More speciﬁcally, CART
markedly enhances hypothalamic and cortical serotonin release in
the rat (Vaarmann and Kask, 2001), but the neuronal circuitry
underpinning this phenomenon is not fully understood. One
possible mechanism could be via CART in the midbrain EWcp
nucleus. More speciﬁcally, functional projections of EWcp neurons
to the dorsal raphe nucleus have been identiﬁed in the rat (Bachtell
et al., 2004; Kozicz, 2010; Turek and Ryabinin, 2005). Therefore,
EWcp CART neurons could control the activity of serotoninergic
neurons in the dorsal raphe nucleus by releasing CART, thereby
modulating the activity of these neurons, and consequently the
serotonin tone in limbic forebrain structures. The question if nes-
fatin/NUCB2 could also play a role in controlling/modulating the
brain’s monoaminergic system remains at future issue.
MDD is associated with various symptoms (e.g. anhedonia,
appetite dysregulation), which may result from impairments of
affected brain regions and disturbed neuropeptide dynamics. As
follow we will discuss several lines of (correlative) evidence sup-
porting the possible involvement of EWcp CART and nesfatin/
NUCB2 in the pathobiology of these symptoms.
An increasing body of evidence shows that drugs producing
hedonic effects (e.g. alcohol, methylphenidate, cocaine and meth-
amphetamine) consistently lead to increased neuronal activity of
EWcp in rodents (Ryabinin and Weitemier, 2006; Spangler et al.,
2009; Trinh et al., 2003). In addition, studies with alcohol
conﬁrmed that EWcp is not only involved in mediating effects of
drugs, but also in their addictive potential (Bachtell et al., 2002,
2003). There is substantial evidence connecting CART with
reward circuitries in the mammalian brain (for review see e.g.:
Rogge et al., 2008; Shirayama and Chaki, 2006). More speciﬁcally, in
a Korean population, association was found between a poly-
morphism in intron 1 of the CART gene and alcoholism (Jung et al.,
2004), and CART-peptide containing neurons are activated by acute
administration of psychostimulants (Rogge et al., 2008; Shirayama
and Chaki, 2006).
Sex-speciﬁcity has been consistently found in stress adaptation
and stress-induced brain diseases (Aﬁﬁ, 2007; Kessler et al., 2003).Interestingly, depression is twice as common among women than
men (Gorman, 2006; Weissman et al., 1996), and females reveal
two- to three-fold higher rates of suicide attempts (Weissman et al.,
1999). Although the samples size utilized in the present study is
admittedly small, we note that this was sufﬁciently large to
demonstrate statistically signiﬁcant, strong differences in CART
and nesfatin/NUCB2 mRNA expression between the experimental
groups. Therefore, our study suggests -notwithstanding the above
mentioned limitations in our study design- a sex difference in CART
and nesfatin/NUCB2 mRNA expressions in the EWcp of depressed
suicide victims, which may contribute to the sex-speciﬁc pathobi-
ology of MDD. Interestingly, male suicide victims showed higher
nesfatin/NUCB2 mRNA expression than controls whereas in female
suicides this mRNA was lower than in the control persons. Two
recent studies supported the hypothesized association between
obesity and depression outcomes for women but not men (Atlantis
and Baker, 2008; Needham and Crosnoe, 2005). Since central
nesfatin-1 is clearly associated with feeding (Kohno et al., 2008; Oh
et al., 2006) our demonstration of a possible sex-speciﬁc dysregu-
lation of nesfatin/NUCB2 mRNA in the EWcp in suicide victims
suggests that nesfatin/NUCB2 in the human EWcp may play a sex-
speciﬁc role in e.g. the dysregulation of appetite in MDD. Such
amechanisms for central action for nesfatin/NUCB2 could be further
supported by the fact that stress, a major trigger inducing appetite,
affects nesfatin-1 neurons in several brain nuclei, including the
EWcp (Goebel-Stengel et al., 2011; Stengel et al., 2009; Xu et al.,
2010; Yoshida et al., 2010). In contrast, alterations in food intake
(2-days fasting) do not effect nesfatin/NUCB2 expression in EWcp
(Okere et al., 2010; Xu et al., 2009, 2010). Taken together, these data
strongly suggest that nesfatin/NUCB2 in the EWcp is primarily
involved in the stress response, and its inﬂuence on appetite regu-
lation could be secondary induced by stress.
In conclusion, we have found a difference in the expression of
CART and nesfatin/NUCB2 in the midbrain of depressed suicide
victims vs. controls that may imply a role for EWcp CART and
nesfatin/NUCB2 in the aetiology major depression c.q. suicidality.
Our data also resonate with recent interest in examining interac-
tions between traditional mood substrates and pathways involved
in the control of food intake and metabolism (for reviews see e.g.:
Gomez-Pinilla, 2008; Krishnan and Nestler, 2008). There could be
several candidate brain centres within which complex interactions
between peripheral metabolic signals and centrally released regu-
lators of feeding and arousal could underpin the general theme that
an animal’s metabolic status greatly inﬂuences mood and motiva-
tion. We propose that one of these centres could be the recently
identiﬁed population of midbrain centrally projecting neurons in
the Edinger-Westphal nucleus.
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